Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
Options
BORIS DOI
Publisher DOI
PubMed ID
22228451
Description
In the HD14 trial, 2×BEACOPPescalated+2×ABVD (2+2) has improved the primary outcome. Compared with 4×ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
Behringer, K | |
Thielen, I | |
Mueller, H | |
Goergen, H | |
Eibl, A D | |
Rosenbrock, J | |
Halbsguth, T | |
Eichenauer, D A | |
Fuchs, M | |
Reiners, K S | |
Renno, J H | |
van der Ven, K | |
Kuehr, M | |
Diehl, V | |
Engert, A | |
Borchmann, P |
Additional Credits
Universitätsklinik für Frauenheilkunde
Series
Annals of oncology
Publisher
Oxford University Press
ISSN
0923-7534
Related URL(s)
https://boris.unibe.ch/150976/
Access(Rights)
open.access